Journal Title
STEM CELLS

STEM CELLS

ISSN / eISSN
1066-5099 / 1549-4918
Aims and Scope
STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.
STEM CELLS covers:

Cancer Stem Cells,
Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells,
Regenerative Medicine,
Stem Cell Technology: Epigenetics, Genomics, Proteomics, and Metabonomics,
Tissue-Specific Stem Cells,
Translational and Clinical Research.
Subject Area

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

HEMATOLOGY

CELL & TISSUE ENGINEERING

CiteScore
10.60 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - General Medicine Q1 #55/830
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY - SCIE Q1
CELL & TISSUE ENGINEERING - SCIE Q2
CELL BIOLOGY - SCIE Q2
HEMATOLOGY - SCIE Q2
ONCOLOGY - SCIE Q2
H-index
205
Country/Area of Publication
UNITED STATES
Publisher
Wiley-Blackwell
Publication Frequency
Monthly
Year Publication Started
1993
Annual Article Volume
108
Open Access
NO
Contact
ALPHAMED PRESS, 318 BLACKWELL ST, STE 260, DURHAM, USA, NC, 27701-2884
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Now submissions require a 90-dollar review fee, and upon acceptance, a 2000-dollar page fee will be charged.
2023-07-19
I want to ask, after being rejected by Stem Cells Translational Medicine, can I still submit to stem cells?
2021-01-08

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now